Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

about

MicroRNA implications across neurodevelopment and neuropathology.Efficient siRNA delivery by the cationic liposome DOTAP in human hematopoietic stem cells differentiating into dendritic cells.Compositions and methods for treatment of Parkinson's disease: a patent evaluation of WO2011/102847A1.

P2860

Q37617954-3C45EBB5-037C-49D3-89FE-4621F5DBC253 Q43120358-2C66FCD1-F26E-49B8-9072-B72C5D06B5B1 Q48710371-1E093952-5ED0-49B8-83F7-CFC96CFE1E21

P2860

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

Item

http://www.wikidata.org/entity/Q57675694

description

im Oktober 2008 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2008

@uk

name

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

@en

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

@nl

type

Item

label

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

@en

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

@nl

prefLabel

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

@en

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

@nl

P1476

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

@en

P2093

Aldo Orlacchio

http://www.w3.org/2001/XMLSchema#string

Giorgio Bernardi

http://www.w3.org/2001/XMLSchema#string

P2860

The nuclear RNase III Drosha initiates microRNA processing

Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs

The Microprocessor complex mediates the genesis of microRNAs

The Drosha-DGCR8 complex in primary microRNA processing

MicroRNA maturation: stepwise processing and subcellular localization.

Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs

RNA interference: biology, mechanism, and applications

Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?

Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake.

Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists

P304

1161-1174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543776.18.10.1161

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sabata Martino

Antonio Orlacchio

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

neurodegeneration

patent

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

about

P2860

P2860

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P921